Laboratorio Reig Jofre (XMAD:RJF) Margin of Safety % (DCF Dividends Based): N/A (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAD:RJF Laboratorio Reig Jofre SA XMAD:RJF
80 GF Score
Price €2.62
GF Value €2.72
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Laboratorio Reig Jofre Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Laboratorio Reig Jofre's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

XMAD:RJF vs ZTS, UTHR, VTRS: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorio Reig Jofre's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laboratorio Reig Jofre Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laboratorio Reig Jofre's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Laboratorio Reig Jofre's Margin of Safety % (DCF Dividends Based) falls into.


XMAD:RJF
80GF Score
Laboratorio Reig Jofre SA XMAD:RJF
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Laboratorio Reig Jofre (XMAD:RJF) Overvalued in 2026?

Based on GuruFocus' analysis, Laboratorio Reig Jofre stock appears to be undervalued. The current stock price of €2.62 is trading 3.7% below its estimated GF Value™ of €2.72. GuruFocus considers Laboratorio Reig Jofre to be Fairly Valued.

Key valuation signals for XMAD:RJF:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: €2.72 vs. price of €2.62 (3.7% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the XMAD:RJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laboratorio Reig Jofre Business Description

Other Exchanges 0RB1:UKFEQ1:Germany
Address Avenida de les Flors, Sant Joan Despi, Barcelona, ESP, 08970
Laboratorio Reig Jofre SA is a healthcare and pharmaceutical developing company. The company focuses on the development of technological-specialization products (antibiotics and injectable products); therapeutic-specialization products in the areas of dermatology, gynecology and respiratory; and consumer healthcare products. It has a broad portfolio of products that the company divides into three categories: products from specialized technology such as antibiotics, injectable, and freeze-dried products.
80GF Score

Get the complete analysis for XMAD:RJF

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.62
Price
€2.72
GF Value